ATE468123T1 - Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität - Google Patents

Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität

Info

Publication number
ATE468123T1
ATE468123T1 AT03760696T AT03760696T ATE468123T1 AT E468123 T1 ATE468123 T1 AT E468123T1 AT 03760696 T AT03760696 T AT 03760696T AT 03760696 T AT03760696 T AT 03760696T AT E468123 T1 ATE468123 T1 AT E468123T1
Authority
AT
Austria
Prior art keywords
aggressiveness
anxiety
pheromones
calming
bird
Prior art date
Application number
AT03760696T
Other languages
English (en)
Inventor
Patrick Pageat
Original Assignee
Fideline
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fideline filed Critical Fideline
Application granted granted Critical
Publication of ATE468123T1 publication Critical patent/ATE468123T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Anesthesiology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Feed For Specific Animals (AREA)
AT03760696T 2002-06-19 2003-06-19 Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität ATE468123T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US38976802P 2002-06-19 2002-06-19
EP02291533 2002-06-19
PCT/EP2003/007144 WO2004000336A1 (en) 2002-06-19 2003-06-19 Avian appeasing pheromones to decrease stress, anxiety and aggressiveness

Publications (1)

Publication Number Publication Date
ATE468123T1 true ATE468123T1 (de) 2010-06-15

Family

ID=42635094

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03760696T ATE468123T1 (de) 2002-06-19 2003-06-19 Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität

Country Status (12)

Country Link
EP (1) EP1531839B1 (de)
JP (1) JP4863619B2 (de)
CN (1) CN100508968C (de)
AT (1) ATE468123T1 (de)
AU (1) AU2003246372B8 (de)
BR (1) BRPI0311934B1 (de)
CA (1) CA2490681C (de)
DK (1) DK1531839T3 (de)
ES (1) ES2345099T3 (de)
MX (1) MXPA04013005A (de)
PT (1) PT1531839E (de)
WO (1) WO2004000336A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114732810A (zh) 2014-03-18 2022-07-12 信息化学与应用动物行为学研究院 猫安抚信息素
US10596137B2 (en) * 2015-02-20 2020-03-24 Societe Des Produits Nestle S.A. Medium chain fatty acids and their triglycerides for treating anxiety
US9943480B2 (en) * 2015-11-03 2018-04-17 Wisconsin Alumni Research Foundation Compositions containing preen oil and methods of use thereof
BE1023693B1 (nl) 2016-06-15 2017-06-16 Vervaeke-Belavi Nv Werkwijze voor het produceren van kuikens
US11529418B2 (en) 2017-12-22 2022-12-20 Ceva Sante Animale Temperature-controlled semiochemical composition diffusers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3039817B2 (ja) * 1990-09-28 2000-05-08 株式会社資生堂 シャンプー組成物
US5272134A (en) * 1992-03-24 1993-12-21 Erox Corporation Fragrance compositions and other compositions which contain human pheromones
FR2715069B1 (fr) * 1994-01-20 1996-04-05 Rene Laversanne Procédé pour améliorer la rémanence d'une odeur.
DE19511572C2 (de) * 1995-03-29 1998-02-26 Henkel Kgaa Niedrigviskose Trübungsmittelkonzentrate
DE19615777C2 (de) * 1996-04-20 1999-04-01 Henkel Kgaa Verwendung von Milchsäure-Milchsäureester-Mischungen
GB9720814D0 (en) * 1997-10-01 1997-12-03 Kiotech Limited Pheromone composition
BR9917806B1 (pt) * 1998-01-21 2013-06-18 composiÇço de feromona para tratamento de estresse ou ansiedade em mamÍferos, e soluÇço.
JP4750232B2 (ja) * 1998-01-21 2011-08-17 フィドゥラン ストレス、不安および攻撃性を低減するブタ鎮静フェロモン
US6054481A (en) * 1998-01-21 2000-04-25 Fideline Pig appeasing pheromones for enhancing weight gain in a mammal
CN1666742A (zh) * 1998-11-02 2005-09-14 三角药物公司 对乙型肝炎病毒的联合治疗

Also Published As

Publication number Publication date
JP2006508038A (ja) 2006-03-09
WO2004000336A1 (en) 2003-12-31
ES2345099T3 (es) 2010-09-15
JP4863619B2 (ja) 2012-01-25
CA2490681C (en) 2012-01-24
BRPI0311934B1 (pt) 2015-05-26
CN1668318A (zh) 2005-09-14
AU2003246372A1 (en) 2004-01-06
DK1531839T3 (da) 2010-09-13
CA2490681A1 (en) 2003-12-31
EP1531839A1 (de) 2005-05-25
EP1531839B1 (de) 2010-05-19
AU2003246372B8 (en) 2009-03-26
MXPA04013005A (es) 2005-09-12
PT1531839E (pt) 2010-07-21
AU2003246372B2 (en) 2008-11-27
BR0311934A (pt) 2005-04-05
CN100508968C (zh) 2009-07-08

Similar Documents

Publication Publication Date Title
ATE239464T1 (de) Pheromone enthaltende zusammensetzung zur minderung von stress, angst und streitsucht in schweinen
BRPI0515316A (pt) compostos de imidazoquinolina
ATE397936T1 (de) Therapeutische verfahren unter verwendung von pflanzlichen zusammensetzungen
GT200500363A (es) 3-amino-pirazol [3,4b] piridinas con inhibidores de proteintirosinquinasas, su preparacion y uso como medicamento.
RS50325B (sr) Imunostimulatorne nukleinske kiseline
DE602005007188D1 (de) Zuckerlacton enthaltende zusammensetzung zur haarbehandlung
EA200700382A1 (ru) Фунгицидные композиции
BRPI0510526A (pt) formulações lìquidas estabilizadas de interferon
TR200001688T2 (tr) TTS içeren bir antioksidant.
RS53723B1 (en) HUMAN VIRUS VIRUS, ASSOCIATED WITH ITS PREPARATION AND PROCEDURES
ATE245427T1 (de) Neue verwendung von phospholipiden tierischen ursprungs in der therapie und/oder schonkost
DE502007004498D1 (de) O/w emulsion zur pflege der hand
ATE468123T1 (de) Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität
ATE359072T1 (de) Methode und zusammensetzung zur behandlung von resistenz gegen antihypertensiva und verwandten zuständen
SV2006002122A (es) Prodrogas de estriol y estetrol ref. p-sv-78.343/msu
DK1735005T3 (da) Fremgangsmåde til indkapsling af oralt indtagne materialer til ændring af fordøjelsesstedet, virkningsstedet eller stabiliteten
HUP0303902A2 (hu) Interleukin-18-indukáló anyag
DE60219148D1 (de) Pharmazeutische Zusammensetzung zur Verhinderung der Entwicklung und Progression von mykotischen Hautoberflächenerkrankungen
TN2010000058A1 (fr) Composition therapeutique aromatisee a base d'argile
ATE444739T1 (de) Polymerzusammensetzung sowie diese enthaltende darreichungsformen
ATE304374T1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
AR034065A1 (es) Productos capilares que contienen aceites naturales con esteroles y acidos grasos insaturados y empleo de aceites naturales y de preparaciones
ATE251910T1 (de) Zusammensetzungen zur modulierung der immunantwort und zur behandlung entzündlicher krankheiten
DE60332635D1 (de) Beruhigende vogel-pheromone zur verminderung von stress, angst und aggressivität
ATE420652T1 (de) Verwendung omega-3-fettsäurehaltiger öle zur erhöhung der bioverfügbarkeit von pflanzenextrakten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1531839

Country of ref document: EP